IL-1 and IL-6 were found to play a positive regulatory role and participate in the regulation mechanism of bone destruction in RA (26), while IL-23 is highly expressed in the serum of RA patients and is positively correlated with CRP and DAS-28 scores (27). This evidence concerns the gene IL6 and rheumatoid arthritis.